Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | plasminogen activator, urokinase | Starlite/ChEMBL | References |
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Homo sapiens | suppression of tumorigenicity 14 (colon carcinoma) | Starlite/ChEMBL | References |
Bos taurus | Coagulation factor X | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | Mastin | plasminogen activator, urokinase | 414 aa | 340 aa | 24.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0023 | 0.0676 | 0.0648 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0021 | 0.003 | 0.003 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0057 | 1 | 1 |
Onchocerca volvulus | 0.0025 | 0.1268 | 0.1268 | |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0057 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.2978 | 0.2978 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0057 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0057 | 1 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0057 | 1 | 0.5 |
Onchocerca volvulus | 0.0031 | 0.2978 | 0.2978 | |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1268 | 0.1268 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 1 | 1 |
Onchocerca volvulus | 0.0025 | 0.1268 | 0.1268 | |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.131 | 0.131 |
Leishmania major | hypothetical protein, conserved | 0.0057 | 1 | 0.5 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0057 | 1 | 1 |
Onchocerca volvulus | 0.0025 | 0.1268 | 0.1268 | |
Brugia malayi | SEA domain containing protein | 0.0025 | 0.1268 | 0.1268 |
Onchocerca volvulus | 0.0025 | 0.1268 | 0.1268 | |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.003 | 0.003 |
Brugia malayi | Muscle positioning protein 4 | 0.0031 | 0.2978 | 0.2978 |
Toxoplasma gondii | kringle domain-containing protein | 0.0057 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.1268 | 0.1242 |
Onchocerca volvulus | 0.0057 | 1 | 1 | |
Brugia malayi | Kringle domain containing protein | 0.0057 | 1 | 1 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0025 | 0.1268 | 0.1268 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0057 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 14 % | Inhibition of human plasmin using pyroGlu-Phe-Lys-pNA.HCl at 5 uM | ChEMBL. | 24794746 |
Ki (binding) | Inhibition of human pancreas Trypsin using Boc-Gln-Ala-Arg-7-amido-4-methyl coumarin hydrobromide | ChEMBL. | 24794746 | |
Ki (binding) | = 9 nM | Inhibition of human urine urokinase using L-PyroGlu-Gly-Arg-pNA.HCl substrate at 5 uM | ChEMBL. | 24794746 |
Ki (binding) | = 204 nM | Inhibition of recombinant matriptase (unknown origin) using Boc-Gln-Ala-Arg-7-amido-4-methyl coumarin hydrobromide | ChEMBL. | 24794746 |
Ki (binding) | = 640 nM | Inhibition of bovine plasma factor 10a using CH3OCO-D-CHA-Gly-Arg-pNA.AcoH substrate | ChEMBL. | 24794746 |
Ki (binding) | = 1785 nM | Inhibition of human thrombin using Boc-Gln-Ala-Arg-7-amido-4-methyl coumarin hydrobromide | ChEMBL. | 24794746 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.